Table 7.
SCORADa assessment all groups.
| Outcome | Timepoint | Comparison | Unadjusted Mean difference (95% CI) | P-value | Adjustedb Mean difference (95% CI) | P-value |
|---|---|---|---|---|---|---|
| Objective score | 120 | STF—BFR | −0.47 (−2.07, 1.14) | 0.57 | 0.18 (−1.34, 1.71) | 0.81 |
| NEF—BFR | 3.87 (−2.55, 10.30) | 0.24 | 5.43 (−1.79, 12.65) | 0.14 | ||
| NEF—STF | 4.34 (−1.94, 10.62) | 0.18 | 5.25 (−1.63, 12.13) | 0.13 | ||
| Overall | 0.35 | 0.33 | ||||
| 180 | STF—BFR | −0.28 (−0.82, 0.26) | 0.31 | 0.09 (−0.57, 0.75) | 0.80 | |
| NEF—BFR | 1.72 (−2.11, 5.55) | 0.38 | 2.26 (−1.96, 6.48) | 0.29 | ||
| NEF—STF | 2.00 (−1.79, 5.79) | 0.30 | 2.17 (−1.82, 6.17) | 0.29 | ||
| Overall | 0.35 | 0.57 |
BFR, breastfeeding reference group; HC, head circumference; NEF, nutrient enriched formula group; STF, standard term formula group; SCORAD, SCORing Atopic Dermatitis assessment.
a
Results at days 30, 60, 90 and 365 days not reported due to insufficient number of participants with SCORAD assessment.
b
Adjusted for index of relative socio-economic disadvantage quintile.